Finding an easy and safe way to operate LMA with minimal complications.
Conditions
Interventions
Intervention 1: Intervention group: Intravenous propofol 2.5 mg/kg(PROPOFOL1 mg/10 ml, B Braun Co, in Germany) and 0.2 mg/kg cisatracurium (muscle relaxant)(Cisatrecurium 10mg/5ml Rosamed-Iran) were i
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patient age between 18-65 years Physical Condition (ASA I and II) Candidate for elective surgery
Exclusion criteria
Exclusion criteria: Drug sensitivity Emergency patients Patients with full stomach Patients with a history of upper respiratory tract infection Asthma COPD Obesity BMI <40 High ICP
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic changes after injection. Timepoint: Before induction of anesthesia, before, during, and 1, 3 and 5 minutes after LMA insertion. Method of measurement: Hemodynamic changes registration form.;The laryngeal mask airway insertion status after injection. Timepoint: Evaluation of LMA insertion variable changes before, during, and 1, 3 and 5 minutes after LMA insertion. Method of measurement: Ease of masking table, table parameters during insertion, removal of the LMA and duration of surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHashem Jarineshin
Bandare-abbas University of Medical Sciences
Outcome results
None listed